Aldeyra Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aldeyra Therapeutics

04/08/2023 06:27

* Aldeyra Therapeutics Inc  ALDX.OQ  reported a quarterly
adjusted
loss of 15 cents​​ per share for the quarter ended in June. The
mean expectation of eight analysts for the quarter was for a
loss of 31 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aldeyra Therapeutics Inc's reported EPS for the quarter
was a
loss of 15 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aldeyra Therapeutics Inc shares had fallen by 5.6% this
quarter and gained 13.8% so far this year.
    * The company reported a quarterly loss of $8.99 million.
    * Wall Street's median 12-month price target for Aldeyra
Therapeutics Inc is $17.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 4 at 05:27 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.31          -0.15          Beat
 Mar. 31 2023      -0.29          -0.27          Beat
 Dec. 31 2022      -0.31          -0.22          Beat
 Sep. 30 2022      -0.34          -0.25          Beat